EC Number   |
Substrates |
Organism |
Products |
Reversibility  |
|---|
   2.3.1.48 | more |
NuA4 targets histone and nonhistone proteins |
Saccharomyces cerevisiae |
? |
- |
- |
| 2.3.1.48 | more |
HBO1 exerts significant acetyltransferase activity on proteins such as ORC2, MCM2, CDC6, and Geminin in in vitro assays |
Homo sapiens |
? |
- |
- |
| 2.3.1.48 | more |
HBO1 exerts significant acetyltransferase activity on proteins such as ORC2, MCM2, CDC6, and Geminin in in vitro assays |
Mus musculus |
? |
- |
- |
| 2.3.1.48 | more |
high-resolution mass spectrometry investigations identifies 1750 proteins as substrates of the posttranslational modification of acetylation, overview |
Saccharomyces cerevisiae |
? |
- |
- |
| 2.3.1.48 | more |
high-resolution mass spectrometry investigations identifies 1750 proteins as substrates of the posttranslational modification of acetylation, overview. Both human Gcn5 and PCAF have H3 and H2B as main substrates, showing the highest in vitro affinity for H3K14 |
Homo sapiens |
? |
- |
- |
| 2.3.1.48 | more |
high-resolution mass spectrometry investigations identifies 1750 proteins as substrates of the posttranslational modification of acetylation, overview. Hpa3 also acts as D-amino-acid N-acetyltransferase, EC 2.3.1.36 |
Saccharomyces cerevisiae |
? |
- |
- |
| 2.3.1.48 | more |
lysine acetyltransferase (KAT) activity of recombinant human ARD1/NAA10, overview. Arrest defective 1 (ARD1) is the only enzyme known so far to exhibit both N-terminal acetyltransferase (NAT) and N-terminal lysine acetyltransferase (KAT) activities. Only the monomeric rhARD1/NAA10 form, but not the oligomeric form, can acetylate lysine residues of substrate proteins. rhARD1/NAA10-mediated Hsp70 acetylation increased in a time-dependent manner |
Homo sapiens |
? |
- |
- |
| 2.3.1.48 | more |
Nut1 is a mediator of RNA polymerase II transcription subunit 5, that also has histone acetylase activity |
Saccharomyces cerevisiae |
? |
- |
- |
| 2.3.1.48 | more |
quantification of HBsu acetylation by parallel reaction monitoring-tandem mass spectrometry |
Bacillus subtilis |
? |
- |
- |
| 2.3.1.48 | more |
recombinant hARD1/NAA10 exhibits KAT activity, which disappears soon in vitro due to enzyme oligomerization, which results in the loss of KAT activity. While oligomeric recombinant hARD1/NAA10 loses its ability for lysine acetylation, its monomeric form clearly exhibits lysine acetylation activity in vitro. Assay optimization, under optimal conditions, hARD1/NAA10 retains its KAT activity, overview |
Homo sapiens |
? |
- |
- |
